A multicenter phase Ib/II study of DNA-PK inhibitor peposertib (M3814) in combination with capecitabine and radiotherapy in patients with locally advanced rectal cancer Meeting Abstract
| Authors: | Romesser, P. B.; Holliday, E. B.; Philip, T.; Garcia-Carbonero, R.; Capdevila, J.; Tuli, R.; Sarholz, B.; Kuipers, M.; Rodriguez, A.; Diaz-Padilla, I.; Miller, E. D. |
| Abstract Title: | A multicenter phase Ib/II study of DNA-PK inhibitor peposertib (M3814) in combination with capecitabine and radiotherapy in patients with locally advanced rectal cancer |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800003 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.TPS144 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS144 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
